Form 4: Coliseum Capital Sells 3M Shares of UTI

Coliseum Capital Management has reported the sale of 3,000,000 shares of Universal Technical Institute (UTI) common stock.

Summary

• Coliseum Capital Management, LLC and associated entities sold 3,000,000 shares of Universal Technical Institute (UTI) common stock.
• The transaction occurred on June 8, 2026, at a price of $41.40 per share.
• Following the sale, the reporting entities retain beneficial ownership of 971,440 shares.
• The reporting group includes Christopher Shackelton and Adam Gray, who are directors of the issuer.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral-to-negative event, as the exit of a large block of shares by a director-affiliated entity often creates short-term supply pressure on the stock.

Positives

• The transaction represents a significant liquidity event for the reporting shareholder.

Negatives

• The sale of 3,000,000 shares by a major shareholder and director-affiliated group may signal a reduction in long-term conviction or portfolio rebalancing.

Risks

• Large-scale selling by institutional insiders can exert downward pressure on the stock price.
• Potential perception of reduced alignment between major shareholders and the company's long-term strategy.

Future Outlook

No specific forward-looking guidance regarding the company's operations was provided in this filing.

Management Comments

• The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein.

Industry Context

StockSavvy.ai notes that significant divestments by institutional investors who hold board representation often trigger market scrutiny regarding the underlying investment thesis for the education sector.

Comparison to Industry Standards

• The sale of a large block of shares by an institutional director is a standard portfolio management activity, though the scale of 3 million shares is notable relative to the remaining position.
• The transaction aligns with typical SEC Section 16 reporting requirements for directors and 10% owners.

Related Party Transactions

• The filing discloses that the shares are held by Coliseum Capital Partners, L.P. and a separate account investment advisory client of CCM.

Stakeholder Impact

• Shareholders may experience increased volatility due to the large volume of shares sold into the market.

Next Steps

• Continued monitoring of future Form 4 filings to determine if further divestment occurs.

Key Dates

Recommendation

Investors should maintain a hold position until the market absorbs the liquidity provided by this large sale and further clarity is provided on the long-term intentions of the remaining stake.

Keywords

UTI, Universal Technical Institute, Coliseum Capital, Insider Selling, Form 4, Equity Transaction